Aspergillosis
ICD-10 B44 is a billable code used to indicate a diagnosis of aspergillosis.
Aspergillosis is a fungal infection caused by the Aspergillus species, primarily Aspergillus fumigatus, which can lead to a range of clinical manifestations. It is most commonly associated with respiratory infections, particularly in immunocompromised individuals, such as those with HIV/AIDS, cancer patients undergoing chemotherapy, or organ transplant recipients. The infection can present as allergic bronchopulmonary aspergillosis (ABPA), invasive aspergillosis, or chronic pulmonary aspergillosis, each with distinct clinical features and treatment approaches. Symptoms may include cough, fever, chest pain, and hemoptysis. Diagnosis typically involves imaging studies, such as CT scans, and microbiological cultures. Treatment often requires antifungal medications, such as voriconazole or amphotericin B, and may necessitate surgical intervention in severe cases. The management of aspergillosis is particularly challenging in patients with weakened immune systems, necessitating careful monitoring and tailored therapeutic strategies.
Detailed patient history, including immunocompromised status and previous infections.
Patients presenting with respiratory symptoms and a history of immunosuppression.
Ensure clear documentation of the type of aspergillosis and treatment response.
Pulmonary function tests, imaging results, and treatment plans.
Patients with chronic cough and hemoptysis, particularly those with underlying lung disease.
Document any co-existing lung conditions that may complicate the diagnosis.
Used when administering antifungal medications not classified under specific codes.
Document the specific antifungal agent used and the reason for its use.
Infectious disease specialists should ensure that the rationale for unclassified drugs is clearly stated.
Common symptoms include cough, fever, chest pain, and hemoptysis, particularly in immunocompromised patients.
Diagnosis typically involves imaging studies, microbiological cultures, and clinical evaluation of symptoms.
Treatment often includes antifungal medications such as voriconazole or amphotericin B, and may require surgical intervention in severe cases.
